Use flexible Tube Micro Plasma F TP for Lipidomics
Cancer is the leading cause of death in economically developed countries and the second leading cause of death in developing countries. In 2015, over 8.8 million people died of cancer worldwide and the numbers are expected to rise...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PID2020-120306RB-I00
INTEGRAL STAGING, PROGNOSTIC AND DIAGNOSTIC OF CANCER IN LIQ...
184K€
Cerrado
CELLETEST
Liquid Biopsy blood test in lung cancer diagnosis and monito...
71K€
Cerrado
CTCapture_2.0
Advanced platform for profiling of therapeutic targets and f...
150K€
Cerrado
CMPtIMSMS
Cancer metabolic profiling through ion mobility and mass spe...
45K€
Cerrado
CTQ2015-64402-C2-1-R
NUEVAS PLATAFORMAS DE MULTIPLEXADO ELECTROANALITICAS PARA LA...
249K€
Cerrado
CTQ2015-64402-C2-2-R
NUEVAS PLATAFORMAS DE MULTIPLEXADO ELECTROANALITICAS PARA LA...
105K€
Cerrado
Información proyecto BIOplasma
Duración del proyecto: 24 meses
Fecha Inicio: 2019-04-09
Fecha Fin: 2021-04-30
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Cancer is the leading cause of death in economically developed countries and the second leading cause of death in developing countries. In 2015, over 8.8 million people died of cancer worldwide and the numbers are expected to rise above 13 million in 2030 . As a consequence, development of non-invasive, fast and robust methods to detect different types of cancer in an early stage are timely. BIOplasma addresses the essential need for analytical tools that permit the diagnosis of biological tissues. A novel analytical strategy based on the Liquid Chromatography/Mass Spectrometry (LC-MS) using flexible Tube Micro Plasma (FµTP) as ionization source for the identification and quantification of several lipid biomarkers in body fluids is proposed